Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

I Adler

Showing results (81-90 of 202) with videos related to

Pageof 21
Sort By:
The Lancet. Respiratory Medicine|February 1, 2016
NICE guidance on nintedanib for treating idiopathic pulmonary fibrosisSophie Laurenson, Raisa Sidhu, Melinda Goodall, et al.
Journal of Bacteriology|August 1, 1981
Cytoplasmic membrane fraction that promotes septation in an Escherichia coli lon mutantH I Adler, A Carrasco, W Crow, et al.
BMJ (Clinical Research Ed.)|May 26, 2009
Newer agents for blood glucose control in type 2 diabetes: summary of NICE guidanceAmanda I Adler, Elizabeth J Shaw, Tim Stokes, et al.
The Lancet. Oncology|April 3, 2018
NICE guidance on everolimus in combination with exemestane for treatment of advanced HER2-negative, hormone-receptor-positive breast cancer after endocrine therapyMartyn J Burke, Zoe Garrett, Elisabeth George, et al.
The Lancet. Oncology|July 26, 2015
NICE guidance on nintedanib for previously treated locally advanced, metastatic, or locally recurrent non-small-cell lung cancerCaroline J Hall, Nicola Hay, Elisabeth George, et al.
Praxis|October 8, 2009
[New drugs for control of blood glucose in type 2 diabetes: summary of the NICE guidelines]A I Adler, E J Shaw, T Stokes, et al.
Diabetic Medicine : a Journal of the British Diabetic Association|September 25, 2007
Characteristics of adults with and without cystic fibrosis-related diabetesA I Adler, E Gunn, C S Haworth, et al.
The Lancet. Respiratory Medicine|December 11, 2013
NICE guidance on inhaled mannitol for treatment of cystic fibrosisGrace Jennings, Pall F Jonsson, Elisabeth George, et al.
Experimental Gerontology|April 2, 2013
The lifespan-reproduction trade-off under dietary restriction is sex-specific and context-dependentMargo I Adler, Elizabeth J Cassidy, Claudia Fricke, et al.
The Lancet. Respiratory Medicine|January 17, 2014
NICE guidance on omalizumab for severe asthmaRichard A Diaz, Zoe Charles, Elisabeth George, et al.
Pageof 21

Showing results (81-90 of 202) with videos related to

Sort By:
Pageof 21
The Lancet. Respiratory Medicine|February 1, 2016
NICE guidance on nintedanib for treating idiopathic pulmonary fibrosisSophie Laurenson, Raisa Sidhu, Melinda Goodall, et al.
Journal of Bacteriology|August 1, 1981
Cytoplasmic membrane fraction that promotes septation in an Escherichia coli lon mutantH I Adler, A Carrasco, W Crow, et al.
BMJ (Clinical Research Ed.)|May 26, 2009
Newer agents for blood glucose control in type 2 diabetes: summary of NICE guidanceAmanda I Adler, Elizabeth J Shaw, Tim Stokes, et al.
The Lancet. Oncology|April 3, 2018
NICE guidance on everolimus in combination with exemestane for treatment of advanced HER2-negative, hormone-receptor-positive breast cancer after endocrine therapyMartyn J Burke, Zoe Garrett, Elisabeth George, et al.
The Lancet. Oncology|July 26, 2015
NICE guidance on nintedanib for previously treated locally advanced, metastatic, or locally recurrent non-small-cell lung cancerCaroline J Hall, Nicola Hay, Elisabeth George, et al.
Praxis|October 8, 2009
[New drugs for control of blood glucose in type 2 diabetes: summary of the NICE guidelines]A I Adler, E J Shaw, T Stokes, et al.
Diabetic Medicine : a Journal of the British Diabetic Association|September 25, 2007
Characteristics of adults with and without cystic fibrosis-related diabetesA I Adler, E Gunn, C S Haworth, et al.
The Lancet. Respiratory Medicine|December 11, 2013
NICE guidance on inhaled mannitol for treatment of cystic fibrosisGrace Jennings, Pall F Jonsson, Elisabeth George, et al.
Experimental Gerontology|April 2, 2013
The lifespan-reproduction trade-off under dietary restriction is sex-specific and context-dependentMargo I Adler, Elizabeth J Cassidy, Claudia Fricke, et al.
The Lancet. Respiratory Medicine|January 17, 2014
NICE guidance on omalizumab for severe asthmaRichard A Diaz, Zoe Charles, Elisabeth George, et al.
Pageof 21